Transgenic mice, over-expressing the mutated human amyloid precursor protein (APP) gene, provide a valuable tool for investigating the associations between amyloidosis, neuronal dysfunction, and cognitive impairment [19-23]. This evidence concerns the gene APP and amyloidosis.